SCHEMBL7349245

SCHEMBL7349245

COC(OC)c1ccc(CN)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.44
LOXL2 Q9Y4K0 5/20 0.44
MAOB P27338 2/20 0.41
ABAT P80404 1/20 0.41
ST14 Q9Y5Y6 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
PSIP1 O75475 1/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
IDO1 P14902 1/20 0.38
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14829267 0.83 CYP1A2 (0.36) CYP1A2CYP2D6CYP2C19TAAR1IDO1
SCHEMBL27930342 0.83 TAAR1 (0.55) LOXL2MAOBCYP1A2CYP2C19TAAR1
SCHEMBL8955219 0.80 CA12 (0.35) CYP1A2CYP2D6CYP2C19SLC6A4
SCHEMBL9008790 0.79 TDP1 (0.50) CYP1A2CYP2D6CYP2C19TAAR1
SCHEMBL8954887 0.77 IDO1 (0.42) CYP1A2CYP2D6CYP2C19IDO1
SCHEMBL7328733 0.77 TSHR (0.39) CYP1A2CYP2D6CYP2C19IDO1
SCHEMBL19640126 0.77 TTR (0.37) CYP1A2CYP2D6CYP2C19IDO1
SCHEMBL2938648 0.77 LTA4H (0.39) CYP1A2CYP2D6CYP2C19NOS3NOS1
SCHEMBL11249724 0.76 PTGS1 (0.50)
SCHEMBL1781027 0.76 LPL (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240075148-A1 POLY-ION COMPLEX MICELLE KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) 2024-03-07 US disclosed
EP-3505555-B1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE KAWASAKI INST OF INDUSTRIAL PROMOTION (JP) 2024-01-03 EP disclosed
WO-2022145486-A1 POLY-ION COMPLEX MICELLE KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) 2022-07-07 WO disclosed
EP-3971227-A1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE Kawasaki Institute of Industrial Promotion (JP) 2022-03-23 EP disclosed
WO-2021153772-A1 BLUE FLUORESCENT PROBE FOR DETECTING ALDEHYDE DEHYDROGENASE 1A1 国立大学法人 東京大学 2021-08-05 WO disclosed
EP-3166645-B1 SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE TO A METAL BINDING PROTEIN AFFYCON APS (DK) 2021-03-03 EP disclosed
US-10925970-B2 Site selective conjugation of an oligonucleotide conjugate or a small molecule to a metal binding protein AFFYCON APS (DK) 2021-02-23 US disclosed
US-20200207989-A1 FLUORESCENT PROBE FOR ALDH3A1 DETECTION THE UNIVERSITY OF TOKYO (JP) 2020-07-02 US disclosed
US-10441662-B2 Polymer, method for producing polymer, and drug conjugate KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) 2019-10-15 US disclosed
WO-2019163942-A1 POLYMER, METHOD FOR PRODUCING POLYMER, DRUG COMPLEX, AND MICELLE 公益財団法人川崎市産業振興財団 2019-08-29 WO disclosed
WO-2019163943-A1 MEDICINAL COMPOSITION 公益財団法人川崎市産業振興財団 2019-08-29 WO disclosed
EP-3505555-A1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE Kawasaki Institute of Industrial Promotion (JP) 2019-07-03 EP disclosed
US-20190192671-A1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) 2019-06-27 US disclosed
US-9862709-B2 Processes for making compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-01-09 US disclosed
US-20170354743-A1 SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN AFFYCON APS (DK) 2017-12-14 US disclosed
EP-3166645-A1 SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN Affycon ApS (DK) 2017-05-17 EP disclosed
WO-2016005474-A1 SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN AFFYCON APS (DK) 2016-01-14 WO disclosed
US-20120046757-A1 COVALENT MODIFICATION OF METAL SURFACES INTEZYNE TECHNOLOGIES (US) 2012-02-23 US disclosed
WO-1994022444-A1 TRICYCLIC COMPOUNDS FOR INHIBITING PLATELET AGGREGATION SMITHKLINE BEECHAM CORPORATION (US) 1994-10-13 WO disclosed
WO-1994022440-A1 BICYCLIC COMPOUNDS WHICH INHIBIT PLATELET AGGREGATION SMITHKLINE BEECHAM CORPORATION (US) 1994-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10925970-B2 Site selective conjugation of an oligonucleotide conjugate or a small molecule to a metal binding protein CD2BP2, CACYBP, CALCOCO2 HRH3 3634/4885LOXL2 3456/4885MAOB 3429/4885
US-20240075148-A1 POLY-ION COMPLEX MICELLE CLTB, KCNMB1, CHMP4B HRH3 826/4885LOXL2 3650/4885MAOB 1982/4885
US-20120046757-A1 COVALENT MODIFICATION OF METAL SURFACES ITGAL, ITGA1, ITGA5 HRH3 4539/4885LOXL2 677/4885MAOB 1982/4885
US-10441662-B2 Polymer, method for producing polymer, and drug conjugate HAX1, SRRM2, HRH3 HRH3 3/4885LOXL2 565/4885MAOB 1308/4885
US-20190192671-A1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE HAX1, SRRM2, HRH3 HRH3 3/4885LOXL2 565/4885MAOB 1308/4885
US-20170354743-A1 SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN CD2BP2, CACYBP, CALCOCO2 HRH3 3634/4885LOXL2 3456/4885MAOB 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.